Nukkleus Inc. Files 8-K
Ticker: DFNSW · Form: 8-K · Filed: Nov 26, 2025 · CIK: 1787518
Sentiment: neutral
Topics: 8-K, regulatory-filing, company-update
Related Tickers: NUKK
TL;DR
Nukkleus Inc. filed an 8-K on Nov 26, 2025. No specific details yet.
AI Summary
Nukkleus Inc. filed an 8-K on November 26, 2025, reporting on other events and financial statements. The company, formerly known as Brilliant Acquisition Corp. until September 9, 2019, is incorporated in Delaware and headquartered at 575 Fifth Avenue, New York, NY. The filing does not contain specific financial figures or details about the 'other events'.
Why It Matters
This 8-K filing indicates that Nukkleus Inc. has made a regulatory submission, which could contain important updates for investors regarding company events or financial status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose specific material information that would immediately impact risk.
Key Players & Entities
- Nukkleus Inc. (company) — Registrant
- Brilliant Acquisition Corp. (company) — Former company name
- November 26, 2025 (date) — Date of report
- 575 Fifth Avenue, New York, NY (location) — Company address
FAQ
What specific 'Other Events' are being reported by Nukkleus Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information but does not provide specific details within the provided text.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported is November 26, 2025.
When did Nukkleus Inc. change its name from Brilliant Acquisition Corp.?
Nukkleus Inc. changed its name from Brilliant Acquisition Corp. on September 9, 2019.
In which state is Nukkleus Inc. incorporated?
Nukkleus Inc. is incorporated in Delaware.
What is the primary business address of Nukkleus Inc.?
The primary business address of Nukkleus Inc. is 575 Fifth Avenue, 14th Floor, New York, NY 10017.
Filing Stats: 789 words · 3 min read · ~3 pages · Grade level 11.2 · Accepted 2025-11-26 09:00:24
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NUKK The Nasdaq
- $92.00 — sable for one Share of Common Stock for $92.00 per share NUKKW The Nasdaq Stock Ma
- $10.00 — are to be sold at an offering price of $10.00 per Unit, generating gross proceeds to
- $150,000,000 — ross proceeds to SC II of approximately $150,000,000. Each Unit will consist of one Class A
- $22.5 million — for additional gross proceeds of up to $22.5 million. The IPO is expected to close on or abo
Filing Documents
- ea0267370-8k_nukkleus.htm (8-K) — 31KB
- ea026737001ex99-1_nukkleus.htm (EX-99.1) — 8KB
- 0001213900-25-115113.txt ( ) — 251KB
- nukk-20251126.xsd (EX-101.SCH) — 4KB
- nukk-20251126_def.xml (EX-101.DEF) — 26KB
- nukk-20251126_lab.xml (EX-101.LAB) — 36KB
- nukk-20251126_pre.xml (EX-101.PRE) — 25KB
- ea0267370-8k_nukkleus_htm.xml (XML) — 6KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On November 26, 2025, Nukkleus Inc. (the "Company") issued a press release announcing the pricing of the initial public offering (the "IPO") of SC II Acquisition Corp. ("SC II"), a newly formed special purpose acquisition company and indirect subsidiary of the Company. A copy of the Company's press release dated November 26, 2025 relating to the pricing of SC II's IPO is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Other Events
Item 8.01 Other Events. On November 25, 2025, SC II priced its IPO of 15,000,000 units (the "Units"). The Units are to be sold at an offering price of $10.00 per Unit, generating gross proceeds to SC II of approximately $150,000,000. Each Unit will consist of one Class A ordinary share of SC II, par value $0.0001 per share (the "Class A Ordinary Shares"), and one right to receive one-fifth (1/5) of one Class A Ordinary Share upon the consummation of SC II's initial business combination (each, a "Share Right"). SC II has also granted the underwriters an option to purchase up to 2,250,000 Units at the offering price to cover over-allotments for additional gross proceeds of up to $22.5 million. The IPO is expected to close on or about November 28, 2025. SC Capital II Sponsor LLC, a Delaware limited liability company and indirect subsidiary of the Company (the "Sponsor"), in which the Company holds a majority interest, is acting as the sponsor of SC II. Simultaneously with the closing of the IPO, pursuant to a Sponsor Private Placement Units Purchase Agreement, dated November 25, 2025, by and between SC II and the Sponsor, the Sponsor will acquire 255,000 Units (the "Sponsor Units") at a price of $10.00 per Sponsor Unit. The issuance of the Sponsor Units is being made pursuant to an exemption from registration contained in Section 4(a)(2) of the Securities Act.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Nukkleus Inc. dated November 26, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: November 26, 2025 By: /s/ Menachem Shalom Name: Menachem Shalom Title: Chief Executive Officer 2